These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12186863)

  • 61. NF-κB, ERK, p38 MAPK and JNK contribute to the initiation and/or maintenance of mechanical allodynia induced by tumor necrosis factor-alpha in the red nucleus.
    Zhang Q; Wang J; Duan MT; Han SP; Zeng XY; Wang JY
    Brain Res Bull; 2013 Oct; 99():132-9. PubMed ID: 24161765
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phosphatase inhibition potentiates IL-6 production by mast cells in response to FcepsilonRI-mediated activation: involvement of p38 MAPK.
    Boudreau RT; Hoskin DW; Lin TJ
    J Leukoc Biol; 2004 Nov; 76(5):1075-81. PubMed ID: 15316034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression.
    Westermarck J; Li SP; Kallunki T; Han J; Kähäri VM
    Mol Cell Biol; 2001 Apr; 21(7):2373-83. PubMed ID: 11259586
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells.
    Lim W; Ma W; Gee K; Aucoin S; Nandan D; Diaz-Mitoma F; Kozlowski M; Kumar A
    J Immunol; 2002 Feb; 168(4):1759-69. PubMed ID: 11823508
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanisms of mitogen-activated protein kinase inhibition by parathyroid hormone in osteoblast-like cells.
    Hömme M; Schmitt CP; Mehls O; Schaefer F
    J Am Soc Nephrol; 2004 Nov; 15(11):2844-50. PubMed ID: 15504937
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential regulation of CD44 expression by lipopolysaccharide (LPS) and TNF-alpha in human monocytic cells: distinct involvement of c-Jun N-terminal kinase in LPS-induced CD44 expression.
    Gee K; Lim W; Ma W; Nandan D; Diaz-Mitoma F; Kozlowski M; Kumar A
    J Immunol; 2002 Nov; 169(10):5660-72. PubMed ID: 12421945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells.
    Takada Y; Sethi G; Sung B; Aggarwal BB
    Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase.
    Nick JA; Young SK; Arndt PG; Lieber JG; Suratt BT; Poch KR; Avdi NJ; Malcolm KC; Taube C; Henson PM; Worthen GS
    J Immunol; 2002 Nov; 169(9):5260-9. PubMed ID: 12391245
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activation of Jun N-terminal kinase/stress-activated protein kinase pathway by tumor necrosis factor alpha leads to intercellular adhesion molecule-1 expression.
    De Cesaris P; Starace D; Starace G; Filippini A; Stefanini M; Ziparo E
    J Biol Chem; 1999 Oct; 274(41):28978-82. PubMed ID: 10506145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells.
    Zhen X; Uryu K; Wang HY; Friedman E
    Mol Pharmacol; 1998 Sep; 54(3):453-8. PubMed ID: 9730903
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Murine coronavirus replication-induced p38 mitogen-activated protein kinase activation promotes interleukin-6 production and virus replication in cultured cells.
    Banerjee S; Narayanan K; Mizutani T; Makino S
    J Virol; 2002 Jun; 76(12):5937-48. PubMed ID: 12021326
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
    Chuang SM; Liou GY; Yang JL
    Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
    Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
    J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
    Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
    Okano J ; Rustgi AK
    J Biol Chem; 2001 Jun; 276(22):19555-64. PubMed ID: 11278851
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Type II tumour necrosis factor-alpha receptor (TNFR2) activates c-Jun N-terminal kinase (JNK) but not mitogen-activated protein kinase (MAPK) or p38 MAPK pathways.
    Jupp OJ; McFarlane SM; Anderson HM; Littlejohn AF; Mohamed AA; MacKay RH; Vandenabeele P; MacEwan DJ
    Biochem J; 2001 Nov; 359(Pt 3):525-35. PubMed ID: 11672426
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of JNK by cellular stress- and tumor necrosis factor alpha-induced AKT2 through activation of the NF kappa B pathway in human epithelial Cells.
    Yuan ZQ; Feldman RI; Sun M; Olashaw NE; Coppola D; Sussman GE; Shelley SA; Nicosia SV; Cheng JQ
    J Biol Chem; 2002 Aug; 277(33):29973-82. PubMed ID: 12048203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
    Krause D; Lyons A; Fennelly C; O'Connor R
    J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.